NO20004399L - Koleinsyreamider og farmasøytiske sammensetninger - Google Patents

Koleinsyreamider og farmasøytiske sammensetninger

Info

Publication number: NO20004399L
Authority: NO; Norway
Prior art keywords: pharmaceutical compositions; acid amides; cholic acid; cholic; amides
Prior art date: 1998-03-06

Application number

NO20004399A

Other languages

English (en)

Other versions

NO20004399D0 (no

NO317378B1 (no

Inventor

Robert Henry Hesse

Sundara Katugam Srinivas Setty

Malathi Ramgopal

Original Assignee

Res Inst Medicine Chem

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-06

Filing date

2000-09-04

Publication date

2000-11-03

2000-09-04 Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem

2000-09-04 Publication of NO20004399D0 publication Critical patent/NO20004399D0/no

2000-11-03 Publication of NO20004399L publication Critical patent/NO20004399L/no

2004-10-18 Publication of NO317378B1 publication Critical patent/NO317378B1/no

Links

BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 title 1
239000004380 Cholic acid Substances 0.000 title 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 title 1
229960002471 cholic acid Drugs 0.000 title 1
235000019416 cholic acid Nutrition 0.000 title 1
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Immunology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Transplantation (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20004399A 1998-03-06 2000-09-04 Kolensyreamider og farmasoytiske sammensetninger NO317378B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9804861.4A GB9804861D0 (en)	1998-03-06	1998-03-06	Chemical compounds
PCT/GB1999/000681 WO1999045024A1 (en)	1998-03-06	1999-03-08	Cholenic acid amides and pharmaceutical compositions thereof

Publications (3)

Publication Number	Publication Date
NO20004399D0 NO20004399D0 (no)	2000-09-04
NO20004399L true NO20004399L (no)	2000-11-03
NO317378B1 NO317378B1 (no)	2004-10-18

Family

ID=10828156

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004399A NO317378B1 (no)	1998-03-06	2000-09-04	Kolensyreamider og farmasoytiske sammensetninger

Country Status (15)

Country	Link
US (1)	US7235552B1 (no)
EP (1)	EP1060188A1 (no)
JP (1)	JP2002505336A (no)
KR (1)	KR100690037B1 (no)
CN (1)	CN1177860C (no)
AU (1)	AU752992B2 (no)
CA (1)	CA2319763C (no)
CZ (1)	CZ298478B6 (no)
GB (1)	GB9804861D0 (no)
HU (1)	HUP0100854A3 (no)
IL (1)	IL138137A (no)
NO (1)	NO317378B1 (no)
NZ (1)	NZ506139A (no)
WO (1)	WO1999045024A1 (no)
ZA (1)	ZA991841B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1287017T3 (da) *	2000-05-11	2005-12-05	Res Inst Medicine Chem	2-substituerede pregna-1,3,5(10)-trien- og chola-1,3,5(10)-trienderivater og deres biologiske aktivitet
EP1514874A1 (en) *	2003-07-28	2005-03-16	Schering Aktiengesellschaft	Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof
WO2009059239A2 (en) *	2007-11-02	2009-05-07	Mayo Foundation For Medical Education And Research	REDUCING Aβ42 LEVELS AND Aβ AGGREGATION
RU2630577C2 (ru)	2008-12-04	2017-09-11	Чунси ЮЙ	Композиции интенсивного проникновения и их применение
WO2012158794A1 (en)	2011-05-17	2012-11-22	Wisconsin Alumni Research Foundation	N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
ES2725784T3 (es)	2011-07-20	2019-09-27	Univ Brigham Young	Compuestos de ceragenina hidrófobos y dispositivos que incorporan al mismo
US11524015B2 (en)	2013-03-15	2022-12-13	Brigham Young University	Methods for treating inflammation, autoimmune disorders and pain
CN110420211A (zh)	2013-03-15	2019-11-08	布莱阿姆青年大学	治疗炎症、自身免疫性疾病和疼痛的方法
US11690855B2 (en)	2013-10-17	2023-07-04	Brigham Young University	Methods for treating lung infections and inflammation
US20150203527A1 (en)	2014-01-23	2015-07-23	Brigham Young University	Cationic steroidal antimicrobials
US9434759B1 (en) *	2015-05-18	2016-09-06	Brigham Young University	Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en)	2016-03-11	2019-03-12	Brigham Young University	Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
EP3275888B1 (en) *	2016-07-28	2019-09-25	Council of Scientific & Industrial Research	Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof
US10959433B2 (en)	2017-03-21	2021-03-30	Brigham Young University	Use of cationic steroidal antimicrobials for sporicidal activity
US12186328B2 (en)	2019-05-23	2025-01-07	Brigham Young University	Use of CSA compounds to stimulate stem cells and hair growth
US12454547B2 (en)	2022-04-22	2025-10-28	Asteroid Therapeutics	Steroidal compositions and methods of treating lipogenic cancers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1512326A (fr) *	1964-03-27	1968-02-09	Roussel Uclaf	Nouveaux stéroïdes azotés et procédé de préparation
US4217288A (en) *	1977-03-24	1980-08-12	Wisconsin Alumni Research Foundation	Anti-vitamin D compounds
US4172076A (en) *	1977-04-04	1979-10-23	Diamond Shamrock Corporation	Process for preparing steroidal acids and their intermediate derivatives
DE2920092A1 (de) *	1978-05-19	1979-11-29	Wisconsin Alumni Res Found	Antivitamin d-verbindungen und diese enthaltende pharmazeutische zusammensetzungen
GB8505862D0 (en) *	1985-03-07	1985-04-11	Erba Farmitalia	Steroidic 5alpha-reductase inhibitors
ES2083771T3 (es) *	1991-11-07	1996-04-16	Res Inst Medicine Chem	Derivados amidicos de la vitamina d.
JP3493037B2 (ja) *	1991-12-18	2004-02-03	中外製薬株式会社	２２−オキサコレカルシフェロール誘導体とその製造方法
IL105050A0 (en) *	1992-03-27	1993-07-08	Lilly Co Eli	Steroid derivatives
GB9309422D0 (en) *	1993-05-07	1993-06-23	Res Inst Medicine Chem	Chemical compounds
AU3068497A (en) *	1996-05-06	1997-11-26	Bionumerik Pharmaceuticals, Inc.	Process for preparing 27-hydroxy cholesterol and related derivatives
AU5928898A (en) *	1997-01-24	1998-08-18	Regents Of The University Of California, The	Use of fxr, pparalpha and lxralpha activators to restore barrier function, promote epidermal differentiation and inhibit proliferation

1998
- 1998-03-06 GB GBGB9804861.4A patent/GB9804861D0/en not_active Ceased
1999
- 1999-03-08 CZ CZ20003253A patent/CZ298478B6/cs not_active IP Right Cessation
- 1999-03-08 HU HU0100854A patent/HUP0100854A3/hu unknown
- 1999-03-08 IL IL13813799A patent/IL138137A/xx not_active IP Right Cessation
- 1999-03-08 KR KR1020007009596A patent/KR100690037B1/ko not_active Expired - Fee Related
- 1999-03-08 JP JP2000534566A patent/JP2002505336A/ja active Pending
- 1999-03-08 CN CNB998036935A patent/CN1177860C/zh not_active Expired - Fee Related
- 1999-03-08 AU AU32675/99A patent/AU752992B2/en not_active Ceased
- 1999-03-08 WO PCT/GB1999/000681 patent/WO1999045024A1/en not_active Ceased
- 1999-03-08 CA CA002319763A patent/CA2319763C/en not_active Expired - Fee Related
- 1999-03-08 EP EP99937931A patent/EP1060188A1/en not_active Withdrawn
- 1999-03-08 NZ NZ506139A patent/NZ506139A/xx unknown
- 1999-03-08 ZA ZA9901841A patent/ZA991841B/xx unknown
2000
- 2000-08-01 US US09/630,546 patent/US7235552B1/en not_active Expired - Fee Related
- 2000-09-04 NO NO20004399A patent/NO317378B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB9804861D0 (en)	1998-04-29
EP1060188A1 (en)	2000-12-20
CN1177860C (zh)	2004-12-01
JP2002505336A (ja)	2002-02-19
IL138137A (en)	2005-11-20
AU752992B2 (en)	2002-10-03
ZA991841B (en)	1999-09-08
CA2319763C (en)	2008-01-15
CZ298478B6 (cs)	2007-10-17
NZ506139A (en)	2003-06-30
KR100690037B1 (ko)	2007-03-08
CZ20003253A3 (cs)	2001-03-14
HUP0100854A2 (hu)	2001-09-28
NO20004399D0 (no)	2000-09-04
AU3267599A (en)	1999-09-20
CA2319763A1 (en)	1999-09-10
NO317378B1 (no)	2004-10-18
US7235552B1 (en)	2007-06-26
IL138137A0 (en)	2001-10-31
HUP0100854A3 (en)	2002-09-30
WO1999045024A1 (en)	1999-09-10
CN1292797A (zh)	2001-04-25
KR20010041446A (ko)	2001-05-25

Legal Events

Date	Code	Title	Description
2010-11-01	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
DK1095932T3 (da)	2004-09-20	Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme
NO20012245L (no)	2001-07-10	Anthranilsyreamider og anvendelse derav som medikamenter
DK1089726T3 (da)	2002-07-22	Præparat omfattende beta-hydroxy-beta-methylsmørsyre og mindst en aminosyre
HUP0100178A3 (en)	2002-12-28	Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
DE69918233D1 (de)	2004-07-29	Polymilchsäure zusammensetzung und daraus hergestellter film
NO20021401D0 (no)	2002-03-20	Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DK1454907T3 (da)	2009-03-09	Quninazolin og pyridopyrmidin-derivativer
ITMI982280A0 (it)	1998-10-23	Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
NO20016277L (no)	2002-02-28	Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
NO20004399D0 (no)	2000-09-04	Koleinsyreamider og farmasøytiske sammensetninger
NO20006488D0 (no)	2000-12-19	Sammensetning og anvendelse
NO20001914D0 (no)	2000-04-12	<alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
NO20011157D0 (no)	2001-03-07	Benzenderivater og farmasøytisk anvendelse derav
NO954975D0 (no)	1995-12-07	Aromatisk substituerte w-amino-alkansyreamider og alkansyrediamider
IS2841B (is)	2013-08-15	Samstæða hluta og lyfjasamsetningar
NO20034778L (no)	2002-04-16	Farmasöytiske sammensetninger for oral og topisk anvendelse
NO20004277D0 (no)	2000-08-25	Indolderivater og farmasøytiske sammensetninger omfattende det samme
PT878467E (pt)	2002-04-29	Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
DK1005342T3 (da)	2003-03-24	Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
PT1140110E (pt)	2003-11-28	Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
DK0869132T3 (da)	2002-01-07	Steroidforbindelser med svangerskabsforebyggende virkning og anti-osteoporose-virkning
EE9900206A (et)	1999-12-15	N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
DK1066261T3 (da)	2006-01-30	Pyridinderivat og farmaceutisk præparat indeholdende samme
NO20005763D0 (no)	2000-11-14	DHEA-sammensetning og metode